Showing results (21-30 of 530) with videos related to
Sort By:
Pageof 53
Child Development|October 1, 1984
Developmental differences in the comprehension and production of narratives by reading-disabled and normally achieving childrenL Feagans, E J ShortAmerican Journal of Hematology|September 25, 2024
Measurable residual disease monitoring in AML: Prospects for therapeutic decision-making and new drug developmentNicholas J Short, Richard DillonClinics in Podiatric Medicine and Surgery|June 4, 2017
Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and AnkleDaniel J Short, Thomas ZgonisCurrent Oncology Reports|February 17, 2017
Minimal Residual Disease in Acute Lymphoblastic Leukemia: How to Recognize and Treat ItNicholas J Short, Elias JabbourClinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Acute Myeloid Leukemia: Past, Present, and Prospects for the FutureNicholas J Short, Farhad RavandiThe Lancet. Haematology|June 30, 2022
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemiaNicholas J Short, Hagop KantarjianExpert Review of Hematology|May 10, 2016
The safety and efficacy of vosaroxin in patients with first relapsed or refractory acute myeloid leukemia - a critical reviewNicholas J Short, Farhad RavandiAmerican Journal of Hematology|July 24, 2022
Hypomethylating agents for the treatment of myelodysplastic syndromes and acute myeloid leukemia: Past discoveries and future directionsNicholas J Short, Hagop KantarjianClinics in Podiatric Medicine and Surgery|November 21, 2016
Medical Imaging in Differentiating the Diabetic Charcot Foot from OsteomyelitisDaniel J Short, Thomas ZgonisCytobios|January 1, 1981
The lack of a "pleiotypic response' in hepatocyte proliferation induced in the rat by 3,5,3'-triiodothyronineJ Short, D Truitte, M OntellPageof 53